Integrating Ligand and Target-Driven Based Virtual Screening Approaches With in vitro Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer Assay to Identify Novel Hit Compounds Against BCL-2
FRONTIERS IN CHEMISTRY, Vol. 8, Nisan 2020, ISSN: 2296-2646
TUTUMLU GURBET,DOĞAN BERNA,AVSAR TİMUCİN,ORHAN MUGE DİDEM,CALİS SEYMA,DURDAGİ SERDAR
|
New Drug Candidates for Neurodegenerative Diseases Discovered by Virtual Screening Methods and Verified by in-vitro Studies
7 International BAU Drug Design Congress, 19 Aralık 2019
YURTSEVER MİNE
|
Virtual Screening of Two and a half million Compounds for Determination Inhibitors of MDM2 as New Anticancer Molecule Hits: Combined Molecular Docking Simulations, Adme, Metacore and Metadrug Study
5. BAU Drug Design Congress, İstanbul/TÜRKİYE, 19 Ekim 2017
AYDIN GÜLŞAH,YURTSEVER MİNE,DURDAĞI SERDAR
|
Proposing novel MDM2 inhibitors: Combined physics-driven high-throughput virtual screening and in vitro studies
CHEMICAL BIOLOGY & DRUG DESIGN, Temmuz 2020, ISSN: 1747-0277
AYDIN GÜLŞAH, PAKSOY MAİDE NUR, ORHAN MÜGE DİDEM, AVŞAR TİMUÇİN, YURTSEVER MİNE, DURDAĞI SERDAR
|
Integrated Binary QSAR-Driven Virtual Screening and In Vitro Studies for Finding Novel hMAO-B-Selective Inhibitors
Journal of Chemical Information and Modeling, Vol. 60, No. 8, Temmuz 2020, s. 4047-4055, ISSN: 1549-9596
İŞ YUSUF SERHAT, AKSOYDAN BUSECAN, ŞENTÜRK MURAT, YURTSEVER MİNE, DURDAĞI SERDAR
|
Dithiocarbamates and dithiocarbonates containing 6-nitrosaccharin scaffold: Synthesis, antimycobacterial activity and in silico target prediction using ensemble docking-based reverse virtual screening
Elsevier BV, Vol. 1277, Nisan 2023, ISSN: 0022-2860
TRAWALLY MUHAMMED, DEMİR YAZICI KÜBRA, DİNGİŞ BİRGÜL SERAP İPEK, KAYA KEREM, AKDEMİR ATİLLA, GÜZEL AKDEMİR ÖZLEN
|
Identification of Potent E. coli Ribosome Inhibitors Using a Systematic Virtual Screening Approach
19th Asian Chemical Congress, 14 Temmuz 2023
KÜRKÇÜOĞLU LEVİTAS AYŞE ÖZGE, SUNGUR FETHİYE AYLİN, YÜCE MERVE
|
Drug Re-Positioning Studies for Novel HIV-1 Inhibitors Using Binary QSAR Models and Multi-Target-DrivenIn SilicoStudies
MOLECULAR INFORMATICS, Vol. 40, No. 2, Şubat 2021, ISSN: 1868-1743
DOĞAN BERNA, DURDAĞI SERDAR
|
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2: A Combined in silico and in vitro Study
MOLECULAR INFORMATICS, Vol. 41, No. 2, Şubat 2022, ISSN: 1868-1743
DURDAĞI SERDAR, ORHAN MÜGE DİDEM, AKSOYDAN BUSECAN, CALİS SEYMA, DOĞAN BERNA, ŞAHİN KADER, SHAHRAKİ AİDA, IYİSON NECLA BİRGÜL, AVŞAR TİMUÇİN
|
Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 32, No. 1, Ocak 2017, s. 311-330, ISSN: 1475-6366
KAYIK GÜLRU,TÜZÜN NURCAN,DURDAĞI SERDAR
|
In silico design of novel hERG-neutral sildenafil-like PDE5 inhibitors
JOURNAL OF BIOMOLECULAR STRUCTURE DYNAMICS, Vol. 35, No. 13, 2017, s. 2830-2852, ISSN: 0739-1102
KAYİK GULRU,TÜZÜN NURCAN,DURDAĞI SERDAR
|
Ab initio and Comparative 3D Modeling of FAM222A and Target-Driven-Based Virtual Screening for the Identification of Novel Therapeutics
Lisansüstü Eğitim Enstitüsü, Bahçeşehir Üniversitesi, 2022
ZAYED TAREQ JASIM AL-ABDULRAHEEM
|
Ab initio and Comparative 3D Modeling of FAM222A and Target-Driven-Based Virtual Screening for the Identification of Novel Therapeutics
Lisansüstü Eğitim Enstitüsü, Bahçeşehir Üniversitesi, 2022
ZAYED TAREQ JASIM AL-ABDULRAHEEM
|